Brain Aneurysm Treatment Market Scope And Analysis

  • Report Code : TIPRE00004588
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Brain Aneurysm Treatment Market Analysis, Trends, and Scope 2024 to 2031

Buy Now

Brain Aneurysm Treatment Market Report Brain Aneurysm Treatment Market Size and Share Brain Aneurysm Treatment Market Scope and Analysis

Brain Aneurysm Treatment Market Report Scope

Report Attribute Details
Market size in 2022 US$ 3.18 Billion
Market Size by 2031 US$ 11.06 Billion
Global CAGR (2023 - 2031) 15.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Surgery
  • Medication
By Condition
  • Unruptured Aneurysm
  • Ruptured Aneurysm
By End User
  • Hospitals
  • Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Stryker Corporation
  • Microport Scientific Corporation
  • Terumo Corporation
  • Penumbra INC
  • Medtronic
  • Johnson Johnson Services INC
  • Kaneka Corporation
  • Mizuho Medical Co Ltd
  • Adeor Medical AG
  • Evasc Medical Systems Corp

    • Brain Aneurysm Treatment Market News and Recent Developments

    The Brain Aneurysm Treatment Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for brain aneurysm treatment and strategies:

    • The company received 510k clearance of the Target Tetra Detachable Coil. The Target Tetra Detachable Coil combines a new tetrahedral shape and softness level, specifically designed to treat small aneurysms in different parts of the body including brain. (Source: Stryker, Press Release, 2023)
    • The company launched new CEREPAK Detachable Coils in the U.S. The CEREPAK Detachable Coils offer three shapes and multiple coil sizes, providing physicians with comprehensive options to embolize brain aneurysms, including coils shaped specifically to achieve concentric aneurysm filling and contribute large volumetric filling. (Source: CERENOVUS, Inc., Newsletter, 2023)
    • The company received U.S.-FDA approval in April 2020 for its new brain aneurysm Embolization Coil (product name: i-ED COIL) and has been marketing it through Kaneka Medical America LLC since September 2020. By signing a sales alliance agreement with Asahi Intecc USA. Inc., Kaneka intends to further expand the sales in the U.S. market from August 2021. (Source: Kaneka Corporation, Press Release, 2021)

    Brain Aneurysm Treatment Market Report Coverage and Deliverables

    The “Brain Aneurysm Treatment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles